Meta-analysis of the effectiveness and safety of magnetic stimulation for chronic pelvic pain

Huixiang Li, Keqiang Yu, Ping Xue, Jueying Xiang, Jing Wu
American journal of translational research · 2024 · vol. 16(8) , pp. 3572–3581 · doi:10.62347/fint4806 · PMID:39262719 · PMC11384379 · W4402150386
Systematic review / meta-analysis OA: bronze CC0
📄 Open PDF View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by qwen3.7-flash, 2026-10-11 ⓘ

This meta-analysis of eight randomized controlled trials found that extracorporeal magnetic stimulation significantly reduces NIH-CPSI scores and improves maximal urinary flow rate in patients with chronic prostatitis and chronic pelvic pain syndrome.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

OBJECTIVE: To systematically assess the effectiveness and safety of magnetic stimulation (MS) for treating chronic prostatitis (CP) and chronic pelvic pain syndrome (CPPS) through a meta-analysis. METHODS: A comprehensive search of databases including PubMed, The Cochrane Library, EMbase, VIP, Web of Science, WanFang, China Biology Medicine disc (CBMdisc), and China National Knowledge Internet (CNKI) databases was conducted to retrieve randomized controlled trials (RCTs) on MS interventions for CPPS from inception to the present. The search employed keywords such as "MS", "CPPS", and "prostatitis". Data analysis was performed using RevMan 5.4 software, focusing on NIH-Chronic Prostatitis Symptom Index (NIH-CPSI), maximal urinary flow rate (Qmax), and international index of erectile function-5 (IIEF-5) score. RESULTS: Eight RCTs involving 636 patients were included. Our meta-analysis revealed that extracorporeal MS significantly reduced NIH-CPSI scores [MD = -6.65; 95% CI (-8.15, -5.15), P < 0.00001] and improved Qmax [MD = 2.98; 95% CI (1.36, 4.59), P = 0.0003] compared to the control group. Although a trend toward improved IIEF-5 scores was observed [MD = 0.81; 95% CI (-0.34, 1.95), P = 0.17], the results were not significant. CONCLUSION: MS is effective in alleviating clinical symptoms and enhancing Qmax in patients with CP/CPPS.

My notes (saved in your browser only)

Condition tags

chronic_pelvic_pain

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2024) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

References (27)

Source provenance

openalex
last seen: 2026-05-14T06:20:47.804276+00:00
pubmed
last seen: 2026-10-08T21:45:41.987887+00:00
License: CC0 · commercial use OK